Our iPSC lab is equipped with a well-defined infrastructure, state-of-the-art equipment, high-quality reagents, and a team of skilled personnel. We utilize essential components such as iPSC culture media, extracellular matrix (ECM) coatings (like Matrigel), and advanced genome-editing tools (like CRISPR) to facilitate the generation, expansion, and differentiation of iPSCs. 

Our lab is equipped with state-of-the-art imaging systems, flow cytometry, and sequencing technologies, enabling precise monitoring of cellular phenotypes and validation of disease models. These advanced resources support our mission to drive innovation in rare disease modeling, drug discovery, and therapeutic target identification. Additionally, we leverage sophisticated high-throughput instruments, including a 

1. Multi-Electrode Array (MEA), 

2. Seahorse Analyzer,  

3. Cytation 5 for high-throughput imaging, 

To accelerate research and provide comprehensive insights into disease mechanisms and treatment strategies.​